Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis.
Huang DQ, Noureddin N, Ajmera V, Amangurbanova M, Bettencourt R, Truong E, Gidener T, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Yoneda M, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Allen AM, Noureddin M, Loomba R. Huang DQ, et al. Among authors: oz dk. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):829-836. doi: 10.1016/S2468-1253(23)00157-7. Epub 2023 Jul 4. Lancet Gastroenterol Hepatol. 2023. PMID: 37419133 Free PMC article.
Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
Ajmera V, Kim BK, Yang K, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Quach NE, Tu X, Zhang X, Noureddin M, Allen AM, Loomba R. Ajmera V, et al. Among authors: oz dk. Gastroenterology. 2022 Oct;163(4):1079-1089.e5. doi: 10.1053/j.gastro.2022.06.073. Epub 2022 Jul 2. Gastroenterology. 2022. PMID: 35788349 Free PMC article.
Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study.
Kim BK, Bergstrom J, Loomba R, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Truong E, Yang JD, Noureddin M, Allen AM, Loomba R, Ajmera V. Kim BK, et al. Among authors: oz dk. Hepatology. 2023 Dec 1;78(6):1858-1866. doi: 10.1097/HEP.0000000000000470. Epub 2023 May 22. Hepatology. 2023. PMID: 37203233 Free PMC article. Clinical Trial.
MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses.
Noureddin N, Ajmera V, Bergstrom J, Bettencourt R, Huang DQ, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R. Noureddin N, et al. Among authors: oz dk. Aliment Pharmacol Ther. 2023 Nov;58(9):856-865. doi: 10.1111/apt.17707. Epub 2023 Sep 11. Aliment Pharmacol Ther. 2023. PMID: 37694993 Free PMC article.
Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality.
Lee SW, Huang DQ, Bettencourt R, Ajmera V, Tincopa M, Noureddin N, Amangurbanova M, Siddiqi H, Madamba E, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Yoneda M, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R. Lee SW, et al. Among authors: oz dk. Aliment Pharmacol Ther. 2024 Jan;59(1):80-88. doi: 10.1111/apt.17783. Epub 2023 Nov 15. Aliment Pharmacol Ther. 2024. PMID: 37968251 Free PMC article.
Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease.
Noureddin N, Huang DQ, Bettencourt R, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Gidener T, Allen AM, Ajmera V, Loomba R. Noureddin N, et al. Among authors: oz dk. Aliment Pharmacol Ther. 2024 Jun;59(12):1521-1526. doi: 10.1111/apt.17981. Epub 2024 Apr 3. Aliment Pharmacol Ther. 2024. PMID: 38571305
Risk-Adapted Strategy Combining Magnetic Resonance Imaging and Prostate-Specific Antigen Density to Individualize Biopsy Decision in Patients With PI-RADS 3 ``Gray Zone'' Lesions.
Akpinar C, Oz DK, Oktar A, Suer E, Ozden E, Haliloglu N, Gulpinar O, Gokce MI, Gogus C, Baltaci S. Akpinar C, et al. Among authors: oz dk. Clin Genitourin Cancer. 2024 Jun;22(3):102071. doi: 10.1016/j.clgc.2024.102071. Epub 2024 Mar 8. Clin Genitourin Cancer. 2024. PMID: 38555682
11 results